04:18 PM EDT, 07/18/2025 (MT Newswires) -- John C Reed, Executive Vice President, Innovative Medicine, R&D, on July 17, 2025, sold 19,137 shares in Johnson & Johnson ( JNJ ) for $3,129,830. Following the Form 4 filing with the SEC, Reed has control over a total of 10,658 common shares of the company, with 10,658 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/200406/000020040625000172/xslF345X05/wk-form4_1752869553.xml